A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning Oct 22, 2026 · Lauran Neergaard · washingtontimes.com read more » A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck. Read more »